Clinical Trial: Body Donation in HHT

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07826845) titled 'Body Donation in HHT' on March 25, 2025.

Brief Summary: The possibility of body donation in hereditary hemorrhagic telangiectasia (HHT) means that human tissue samples with and without vascular malformations can be analyzed. The aim is to gain insights into the disease mechanism.

Study Start Date: Oct. 01, 2025

Study Type: INTERVENTIONAL

Condition: Hereditary Hemorrhagic Telangiectasia

Intervention: OTHER: body donation in HHT

Body donation in HHT

Recruitment Status: RECRUITING

Sponsor: University Hospital, Essen

Information provided by (Responsible Party): Freya Droege, University Hospital, Essen

Published by HT Digital...